|
Follow the links below to find systematic reviews of the evidence for the effectiveness of treatments for schizophrenia.
Reviewed February 2009
Printer friendly page
| Results 1 to 20 displayed. |
|
1
2
3
4
5
|
| Title: |
Twenty-four hour care for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Schizophrenia is a long-term, chronic, illness with a worldwide lifetime prevalence of about one per cent. It has a high disability rate and the cost to individuals, their carers and health services is substantial.Although the majority of people with s...
|
| Date: |
Apr 2009
|
| Title: |
Polyunsaturated fatty acid supplementation for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Schizophrenia is a serious, chronic and relapsing mental illness with a worldwide lifetime prevalence of approximately one per cent. Early research suggests dietary supplementation with essential fatty acids (EFAs) may have a positive effect on the symp...
|
| Date: |
Feb 2009
|
| Title: |
Sulpiride versus placebo for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Schizophrenia is a severe mental illness characterised by a mixture of symptoms such as hallucinations, delusions, disorganisation and social withdrawal. For some it can be a life-long condition and people with this diagnosis are usually treated with an...
|
| Date: |
Jan 2009
|
| Title: |
Chlorpromazine dose for people with schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Schizophrenia is a serious, chronic and relapsing mental disorder. It has a worldwide lifetime prevalence of about one per cent; roughly 24 million people are suffering from this disease. Schizophrenia is characterised by both positive symptoms, such as...
|
| Date: |
Dec 2008
|
| Title: |
Dance therapy for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Dance therapy or dance movement therapy (DMT) uses movement of the body as a therapeutic tool. It is thought to be effective in the treatment of people with developmental, medical, social, physical and psychological impairment. Dance therapy sessions ca...
|
| Date: |
Nov 2008
|
| Title: |
Monetary incentives for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Money incentivises many. It has been used in experiments to promote various behaviours in people with schizophrenia. We found six trials, but only one compared monetary incentives to no incentives which was the focus of this particular review. This one...
|
| Date: |
Aug 2008
|
| Title: |
Risperidone dose for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Risperidone is one of the first-line antipsychotic drugs for schizophrenia. Balance between gaining positive effects of drugs for an acceptable level of negative outcomes is urgently needed and its optimal dose needs more evidence for support. There are...
|
| Date: |
Jul 2008
|
| Title: |
Pharmacological interventions for clozapine-induced hypersalivation
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Clozapine is widely used for people with schizophrenia. Although agranulocytosis, weight gain, and cardiac problems are serious problems associated with its use, hypersalivation, sometimes of a gross and socially unacceptable quantity, is also common (30-80%).
|
| Date: |
Jul 2008
|
| Title: |
Morita therapy for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Schizophrenia is a long-term, chronic illness with a high disability rate and disease burden. Treatment for schizophrenia should focus on the wider social aspects of living in the community in addition to medicating the immediate symptoms of this long-t...
|
| Date: |
Jul 2008
|
| Title: |
Paliperidone for the treatment of adults with schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Schizophrenia is a mental illness which can cause considerable disability but may be helped by taking antipsychotic medication. However, the medications can cause many different side-effects and people often stop taking them. Paliperidone is a new drug ...
|
| Date: |
May 2008
|
| Title: |
Valproate for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Most people with schizophrenia or schizophrenia-like conditions who are in contact with medical services will be treated with antipsychotic medication. Despite this, about 30% will continue to experience some signs of illness. Various other drugs have b...
|
| Date: |
May 2008
|
| Title: |
Aripiprazole versus typical antipsychotic drugs for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Schizophrenia is a severe mental illness which mostly affects people in early adulthood. The symptoms of schizophrenia are perceptions without cause (hallucinations), fixed false beliefs (delusions) and/or apathy, slowing and less movement or thought. P...
|
| Date: |
Apr 2008
|
| Title: |
Life skills programmes for chronic mental illnesses
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
People with chronic mental illness often experience a cyclical pattern, characterised by more than one relapse in their lifespan. This can affect their ability to care for themselves and function normally. Life skills programmes are one intervention des...
|
| Date: |
Feb 2008
|
| Title: |
Haloperidol versus chlorpromazine for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Chlorpromazine and haloperidol are both standard antipsychotic drugs that are used in the treatment of schizophrenia. Randomised data comparing these agents are sparse, but chlorpromazine use seems to be associated with higher drop-out rates and hypoten...
|
| Date: |
Nov 2007
|
| Title: |
Atypical antipsychotics for people with both schizophrenia and depression
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
It is well known that depression occurs in people with schizophrenia. Atypical antipsychotics are used to treat the symptoms of schizophrenia but their specific effects on those with schizophrenia and depression are unclear, although they are marketed f...
|
| Date: |
Nov 2007
|
| Title: |
Cannabis and schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Schizophrenia is a mental illness characterised mainly by hallucinations and delusions (psychosis) which for the majority of people has an onset in late adolescence or early adulthood. Many people across many cultures, especially the young, use cannabis...
|
| Date: |
Aug 2007
|
| Title: |
Sertindole versus other atypical antipsychotics for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
This review compares the effects of sertindole to other so-called atypical antipsychotics, but we found only two trials, both comparing it with risperidone. On the basis of very limited data there was no difference in efficacy. Sertindole produced more ...
|
| Date: |
Aug 2007
|
| Title: |
Hypnosis for schizophrenia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Antipsychotic medication is the most effective treatment for people with schizophrenia. However some people, despite taking medication, continue to experience symptoms and/or disabling adverse effects. There is thus a growing need to consider alternativ...
|
| Date: |
Aug 2007
|
| Results 1 to 20 displayed. |
|
1
2
3
4
5
|
|
